therapeutic gain

therapeutic gain

the ratio of the biological effect of a therapy on a tumor compared with the effect on surrounding normal tissue. Higher therapeutic gains mean lower complications of therapy.

therapeutic gain

Placebo-subtracted response Research The response in a treatment group minus the response in a control/placebo group. See Placebo effect.
Mentioned in ?
References in periodicals archive ?
The researchers characterized the 10% therapeutic gain over placebo as "modest" and similar to that provided by other accepted therapies for IBS (Am.
The investigators characterized the 10% therapeutic gain over placebo as "modest" and similar to that provided by other accepted therapies for IBS (Am.
How could I advocate for one client's belief system to be used as a source of therapeutic gain while intentionally ignoring another's?
Although the self-disclosure of a counselor could contribute to therapeutic gain, the technique may prove to be ineffective when counselors assume that their own experience matches or equates to that of the client (Egan, 2010; Ivey, Ivey, & Zalaquett, 2010).
Resveratrol seems to have a therapeutic gain by making tumor cells more sensitive to radiation and making normal tissue less sensitive.
By targeting these patients, the biomarkers favorably alter the risk-benefit profile of pharmaceutical drugs, allowing non-responders to avoid potential side effects unbalanced by therapeutic gain.
A priority rating reflects the agency's estimate that the drug represents a significant therapeutic gain over existing remedies, while a standard rating reflects the agency's estimate that the drug offers little to no therapeutic gain.
They noted that prolonged prednisone-free growth catch-up and general well-being was a major therapeutic gain from the procedure.
generally pressure budgets because the increased cost is often out of proportion to the therapeutic gain.
The therapeutic gain, with the rates of response to treatment (i.
They discuss such topics as therapeutic implications of the intrinsic and acquired resistance of cancer stem/progenitor cells in the inefficacy of current cancer treatments and disease relapse, the role of the tumoural micro-environment and its vasculature in chemotherapy drug resistance and the potential for modulating it to achieve therapeutic gain, mechanisms of resistance to epidermal growth factor receptor-tyrosine kinase inhibitor in non-small cell lung cancer cell lines, targeting adverse features of hormone-resistant breast cancer, the clinical importance of molecular structure and energy in drug resistant neoplasms, treating drug resistant malignancy, and overcoming ovarian cancer drug resistance with phytochemicals and other compounds.
Among the women in the study with cervical cancer, "we saw a striking therapeutic gain by the addition of hyperthermia," the investigators noted.

Full browser ?